Guzman-Clark Vanessa 4
4 · Greenlane Holdings, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Greenlane (GNLN) CFO Vanessa Guzman-Clark Receives 81,500 Options
What Happened
- Vanessa Guzman-Clark, Chief Financial Officer of Greenlane Holdings, received a grant/award of 81,500 derivative securities (stock options) on October 20, 2025. The options have an exercise price of $0.01 per share, so exercising all would cost $815 in aggregate. This filing reports an award (A) rather than a market purchase or sale.
Key Details
- Transaction date: 2025-10-20; Form 4 filed: 2026-03-17 (appears to be filed late).
- Option terms: 81,500 options, exercise price $0.01 per share (total exercise cost $815).
- Vesting/expiration (from footnotes): options vest in full upon grant and expire five years from the grant date unless earlier terminated under the 2019 Equity Incentive Plan.
- Allocation source: portion of a 3,000,000-share ESOP distribution approved Oct 14, 2025.
- Shares owned after transaction: not specified in the filing.
- Filing timeliness: transaction occurred on 2025-10-20 but Form 4 was submitted on 2026-03-17 (delayed reporting).
Context
- These are option awards (derivative securities). Because they vest immediately, they are exercisable now, but the filing records a grant—there is no reported exercise or sale here. Exercising would require paying the $0.01 strike per share. The late filing reduces near-term transparency but does not change the nature of the award itself.
Insider Transaction Report
Form 4
Guzman-Clark Vanessa
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
[F1][F2][F3]2025-10-20$0.01/sh+81,500$815→ 81,500 totalExercise: $3.84Exp: 2030-10-20→ Class A Common Stock (81,500 underlying)
Footnotes (3)
- [F1]The exercise price equals the closing price of Greenlane Holdings, Inc. (the "Company") Class A Common Stock on October 17, 2025.
- [F2]The option allocation is from the Company's 3,000,000 share ESOP distribution approved and ratified by the Board of Directors of the Company on October 14, 2025.
- [F3]Options vest in full upon grant in consideration of executive service and expire five (5) years from the grant date, unless earlier terminated under the Company's 2019 Equity Incentive Plan.
Signature
/s/ Vanessa Guzman-Clark|2026-03-17